Skip to content


Asarina Pharma is a Swedish public limited company and governed by Swedish legislation, mainly the Swedish Companies Act (2005: 551) and the Swedish Annual Accounts Act (1995: 1554). Following the listing of the Company’s shares on First North, the Company will also apply First North’s rules.

In addition to swedish legislation and First North’s regulations, it is the Company’s Articles of Association and its internal corporate governance guidelines that underpin the Company’s corporate governance. The articles of association state, among other things, the seat of the Board, the focus of the business, the limits of the share capital and the number of shares and the conditions for attendance at the Annual General Meeting